DNA methylation, an epigenetic mode of gene expression regulation in reproductive science

Current Pharmaceutical Design

Volumn 20, Issue 11, 2014, Pages 1726-1750

  Calicchio, Rosamaria ^a,b,c   Doridot, Ludivine ^a,b,c   Miralles, Francisco ^a,b,c   Méhats, Céline ^a,b,c   Vaiman, Daniel ^a,b,c  

^a INSTITUT COCHIN   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

DNA methylation; Epigenetics; Imprinted genes; Infertility; Medically assisted reproduction; Placenta; Reproduction; Sperm

Indexed keywords

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; ENDOMETRIOSIS; EPIGENETICS; GENE CONTROL; GENE EXPRESSION REGULATION; HIGH THROUGHPUT SEQUENCING; HUMAN; INFERTILITY THERAPY; INTRAUTERINE GROWTH RETARDATION; NONHUMAN; OVARY; OVARY DISEASE; OVARY POLYCYSTIC DISEASE; PLACENTA DISORDER; PREECLAMPSIA; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; REPRODUCTION; SPERMATOGENESIS; ANIMAL; FEMALE; GENETIC EPIGENESIS; GENETICS; GENOME IMPRINTING; PHYSIOLOGY; PREGNANCY;

ANIMALS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION; GENOMIC IMPRINTING; HUMANS; PREGNANCY; REPRODUCTION; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 84903726489     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128113199990517     Document Type: Article

References (193)

1. Watson JD, Crick FH. Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature 1953; 171: 737-8.
2. Eickbush TH, Moudrianakis EN. The compaction of DNA helices into either continuous supercoils or folded-fiber rods and toroids. Cell 1978; 13: 295-306.
3. Guil S, Esteller M. DNA methylomes, histone codes and miRNAs: tying it all together. Int J Biochem Cell Biol 2009; 41: 87-95.
4. Kinney SR, Pradhan S. Regulation of expression and activity of DNA (cytosine-5) methyltransferases in mammalian cells. Prog Mol Biol Transl Sci 2011; 101: 311-33.
5. De Carvalho DD, You JS, Jones PA. DNA methylation and cellular reprogramming. Trends Cell Biol 2010; 20: 609-17.
6. Guo JU, Su Y, Zhong C, Ming GL, Song H. Hydroxylation of 5- methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 2011; 145: 423-34.
7. Niehrs C, Schafer A. Active DNA demethylation by Gadd45 and DNA repair. Trends Cell Biol 2012; 22: 220-7.
8. Iqbal K, Jin SG, Pfeifer GP, Szabo PE. Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine. Proc Natl Acad Sci USA 2011; 108: 3642-7.
9. Luedi PP, Dietrich FS, Weidman JR, Bosko JM, Jirtle RL, Hartemink AJ. Computational and experimental identification of novel human imprinted genes. Genome Res 2007; 17: 1723-30.
10. Barbaux S, Gascoin-Lachambre G, Buffat C, et al. A genome-wide approach reveals novel imprinted genes expressed in the human placenta. Epigenetics 2012: in press.
11. Smits G, Mungall AJ, Griffiths-Jones S, et al. Conservation of the H19 noncoding RNA and H19-IGF2 imprinting mechanism in therians. Nat Genet 2008; 40: 971-6.
12. Kato Y, Sasaki H. Imprinting and looping: epigenetic marks control interactions between regulatory elements. Bioessays 2005; 27: 1-4.
13. Krueger C, Osborne CS. Raising the curtains on interchromosomal interactions. Trends Genet 2006; 22: 637-9.
14. Kajii T, Ohama K. Androgenetic origin of hydatidiform mole. Nature 1977; 268: 633-4.
15. Murdoch S, Djuric U, Mazhar B, et al. Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nat Genet 2006; 38: 300-2.
16. Bestor TH, Bourc'his D. Genetics and epigenetics of hydatidiform moles. Nat Genet 2006; 38: 274-6.
17. Holliday R, Pugh JE. DNA modification mechanisms and gene activity during development. Science 1975; 187: 226-32.
18. Riggs AD. X inactivation, differentiation, and DNA methylation. Cytogenet Cell Genet 1975; 14: 9-25.
19. Bird AP, Southern EM. Use of restriction enzymes to study eukaryotic DNA methylation: I. The methylation pattern in ribosomal DNA from Xenopus laevis. J Mol Biol 1978; 118: 27-47.
20. Cedar H, Solage A, Glaser G, Razin A. Direct detection of methylated cytosine in DNA by use of the restriction enzyme MspI. Nucleic Acids Res 1979; 6: 2125-32.
21. Adouard V, Dante R, Niveleau A, Delain E, Revet B, Ehrlich M. The accessibility of 5-methylcytosine to specific antibodies in double- stranded DNA of Xanthomonas phage XP12. Eur J Biochem 1985; 152: 115-21.
22. Hendrich B, Bird A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol 1998; 18: 6538-47.
23. Hayatsu H, Wataya Y, Kai K, Iida S. Reaction of sodium bisulfite with uracil, cytosine, and their derivatives. Biochemistry 1970; 9: 2858-65.
24. Hayatsu H, Wataya Y, Kazushige K. The addition of sodium bisulfite to uracil and to cytosine. J Am Chem Soc 1970; 92: 724-6.
25. Wang RY, Gehrke CW, Ehrlich M. Comparison of bisulfite modification of 5-methyldeoxycytidine and deoxycytidine residues. Nucleic Acids Res 1980; 8: 4777-90.
26. Frommer M, McDonald LE, Millar DS, et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 1992; 89: 1827-31.
27. Lister R, Ecker JR. Finding the fifth base: genome-wide sequencing of cytosine methylation. Genome Res 2009; 19: 959-66.
28. Bock C, Tomazou EM, Brinkman AB, et al. Quantitative comparison of genome-wide DNA methylation mapping technologies. Nat Biotechnol 2010; 28: 1106-14.
29. Harris RA, Wang T, Coarfa C, et al. Comparison of sequencingbased methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nat Biotechnol 2010; 28: 1097-105.
30. Deng J, Shoemaker R, Xie B, et al. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat Biotechnol 2009; 27: 353-60.
31. Layman LC. Human gene mutations causing infertility. J Med Genet 2002; 39: 153-61.
32. Matzuk MM, Lamb DJ. The biology of infertility: research advances and clinical challenges. Nat Med 2008; 14: 1197-213.
33. Schultz N, Hamra FK, Garbers DL. A multitude of genes expressed solely in meiotic or postmeiotic spermatogenic cells offers a myriad of contraceptive targets. Proc Natl Acad Sci USA 2003; 100: 12201-6.
34. Rousseaux S, Reynoird N, Escoffier E, Thevenon J, Caron C, Khochbin S. Epigenetic reprogramming of the male genome during gametogenesis and in the zygote. Reprod Biomed Online 2008; 16: 492-503.
35. Wykes SM, Krawetz SA. The structural organization of sperm chromatin. J Biol Chem 2003; 278: 29471-7.
36. Ooi SL, Henikoff S. Germline histone dynamics and epigenetics. Curr Opin Cell Biol 2007; 19: 257-65.
37. Oakes CC, La Salle S, Smiraglia DJ, Robaire B, Trasler JM. Developmental acquisition of genome-wide DNA methylation occurs prior to meiosis in male germ cells. Dev Biol 2007; 307: 368-79.
38. Benchaib M, Ajina M, Lornage J, Niveleau A, Durand P, Guerin JF. Quantitation by image analysis of global DNA methylation in human spermatozoa and its prognostic value in in vitro fertilization: a preliminary study. Fertil Steril 2003; 80: 947-53.
39. Navarro-Costa P, Nogueira P, Carvalho M, et al. Incorrect DNA methylation of the DAZL promoter CpG island associates with defective human sperm. Hum Reprod 2010; 25: 2647-54.
40. Ghorbian S. Routine diagnostic testing of Y chromosome deletions in male infertile and subfertile. Gene 2012; 503: 160-4.
41. Wu W, Lu C, Xia Y, et al. Lack of association between DAZ gene methylation patterns and spermatogenic failure. Clin Chem Lab Med 2010; 48: 355-60.
42. Linher K, Cheung Q, Baker P, Bedecarrats G, Shiota K, Li J. An epigenetic mechanism regulates germ cell-specific expression of the porcine Deleted in Azoospermia-Like (DAZL) gene. Differentiation 2009; 77: 335-49.
43. Sugimoto K, Koh E, Sin HS, et al. Tissue-specific differentially methylated regions of the human VASA gene are potentially associated with maturation arrest phenotype in the testis. J Hum Genet 2009; 54: 450-6.
44. Medrano JV, Ramathal C, Nguyen HN, Simon C, Reijo Pera RA. Divergent RNA-binding proteins, DAZL and VASA, induce meiotic progression in human germ cells derived in vitro. Stem Cells 2012; 30: 441-51.
45. Marques CJ, Carvalho F, Sousa M, Barros A. Genomic imprinting in disruptive spermatogenesis. Lancet 2004; 363: 1700-2.
46. Marques CJ, Costa P, Vaz B, et al. Abnormal methylation of imprinted genes in human sperm is associated with oligozoospermia. Mol Hum Reprod 2008; 14: 67-74.
47. Marques CJ, Francisco T, Sousa S, Carvalho F, Barros A, Sousa M. Methylation defects of imprinted genes in human testicular spermatozoa. Fertil Steril 2010; 94: 585-94.
48. Pacheco SE, Houseman EA, Christensen BC, et al. Integrative DNA methylation and gene expression analyses identify DNA packaging and epigenetic regulatory genes associated with low motility sperm. PLoS One 2011; 6: e20280.
49. Kobayashi H, Hiura H, John RM, et al. DNA methylation errors at imprinted loci after assisted conception originate in the parental sperm. Eur J Hum Genet 2009; 17: 1582-91.
50. Boissonnas CC, Abdalaoui HE, Haelewyn V, et al. Specific epigenetic alterations of IGF2-H19 locus in spermatozoa from infertile men. Eur J Hum Genet 2010; 18: 73-80.
51. Fauque P, Jouannet P, Lesaffre C, et al. Assisted Reproductive Technology affects developmental kinetics, H19 Imprinting Con trol Region methylation and H19 gene expression in individual mouse embryos. BMC Dev Biol 2007; 7: 116.
52. Fauque P, Mondon F, Letourneur F, et al. In vitro fertilization and embryo culture strongly impact the placental transcriptome in the mouse model. PLoS One 2010; 5: e9218.
53. Chen SL, Shi XY, Zheng HY, Wu FR, Luo C. Aberrant DNA methylation of imprinted H19 gene in human preimplantation embryos. Fertil Steril 2010; 94: 2356-8, 2358 e1.
54. Bourc'his D, Xu GL, Lin CS, Bollman B, Bestor TH. Dnmt3L and the establishment of maternal genomic imprints. Science 2001; 294: 2536-9.
55. Jia D, Jurkowska RZ, Zhang X, Jeltsch A, Cheng X. Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation. Nature 2007; 449: 248-51.
56. Anway MD, Cupp AS, Uzumcu M, Skinner MK. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 2005; 308: 1466-9.
57. Germain AM, Romanik MC, Guerra I, et al. Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events? Hypertension 2007; 49: 90-5.
58. ESHRE/ASRM. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41-7.
59. Hickey T, Chandy A, Norman RJ. The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome. J Clin Endocrinol Metab 2002; 87: 161-5.
60. Dasgupta S, Sirisha PV, Neelaveni K, et al. Androgen receptor CAG repeat polymorphism and epigenetic influence among the south Indian women with Polycystic Ovary Syndrome. PLoS One 2010; 5: e12401.
61. Nakayama T, Watanabe M, Suzuki H, et al. Epigenetic regulation of androgen receptor gene expression in human prostate cancers. Lab Invest 2000; 80: 1789-96.
62. Xu N, Azziz R, Goodarzi MO. Epigenetics in polycystic ovary syndrome: a pilot study of global DNA methylation. Fertil Steril 2010; 94: 781-3 e1.
63. Zhu JQ, Zhu L, Liang XW, Xing FQ, Schatten H, Sun QY. Demethylation of LHR in dehydroepiandrosterone-induced mouse model of polycystic ovary syndrome. Mol Hum Reprod 2010; 16: 260-6.
64. Xu N, Kwon S, Abbott DH, et al. Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys. PLoS One 2011; 6: e27286.
65. Vaiman D. Fertility, sex determination, and the X chromosome. Cytogenet Genome Res 2002; 99: 224-8.
66. Rizzolio F, Pramparo T, Sala C, et al. Epigenetic analysis of the critical region I for premature ovarian failure: demonstration of a highly heterochromatic domain on the long arm of the mammalian X chromosome. J Med Genet 2009; 46: 585-92.
67. Laisk T, Haller-Kikkatalo K, Laanpere M, et al. Androgen receptor epigenetic variations influence early follicular phase gonadotropin levels. Acta Obstet Gynecol Scand 2010; 89: 1557-63.
68. Bretherick KL, Metzger DL, Chanoine JP, et al. Skewed Xchromosome inactivation is associated with primary but not secondary ovarian failure. Am J Med Genet A 2007; 143A: 945-51.
69. Mansouri MR, Schuster J, Badhai J, et al. Alterations in the expression, structure and function of progesterone receptor membrane component-1 (PGRMC1) in premature ovarian failure. Hum Mol Genet 2008; 17: 3776-83.
70. Sampson J. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927; 14: 422-469.
71. Noel JC, Anaf V, Borghese B, Vaiman D, Fayt I, Chapron C. The steroidogenic factor-1 protein is not expressed in various forms of endometriosis but is strongly present in ovarian cortical or medullary mesenchymatous cells adjacent to endometriotic foci. Fertil Steril 2011: in press.
72. de Ziegler D, Borghese B, Chapron C. Endometriosis and infertility: pathophysiology and management. Lancet 2010; 376: 730-8.
73. Fassbender A, Verbeeck N, Bornigen D, et al. Combined mRNA microarray and proteomic analysis of eutopic endometrium of women with and without endometriosis. Hum Reprod 2012; 27: 2020-9.
74. Zelenko Z, Aghajanova L, Irwin JC, Giudice LC. Nuclear receptor, coregulator signaling, and chromatin remodeling pathways suggest involvement of the epigenome in the steroid hormone response of endometrium and abnormalities in endometriosis. Reprod Sci 2012; 19: 152-62.
75. Lee B, Du H, Taylor HS. Experimental murine endometriosis induces DNA methylation and altered gene expression in eutopic endometrium. Biol Reprod 2009; 80: 79-85.
76. Wu Y, Halverson G, Basir Z, Strawn E, Yan P, Guo SW. Aberrant methylation at HOXA10 may be responsible for its aberrant expression in the endometrium of patients with endometriosis. Am J Obstet Gynecol 2005; 193: 371-80.
77. Szczepanska M, Wirstlein P, Luczak M, Jagodzinski PP, Skrzypczak J. Reduced expression of HOXA10 in the midluteal endometrium from infertile women with minimal endometriosis. Biomed Pharmacother 2010; 64: 697-705.
78. Borghese B, Mondon F, Noel JC, et al. Gene expression profile for ectopic versus eutopic endometrium provides new insights into endometriosis oncogenic potential. Mol Endocrinol 2008; 22: 2557-62.
79. Wang D, Chen Q, Zhang C, Ren F, Li T. DNA hypomethylation of the COX-2 gene promoter is associated with up-regulation of its mRNA expression in eutopic endometrium of endometriosis. Eur J Med Res 2012; 17: 12.
80. Szczepanska M, Wirstlein P, Skrzypczak J, Jagodzinski PP. Expression of HOXA11 in the mid-luteal endometrium from women with endometriosis-associated infertility. Reprod Biol Endocrinol 2012; 10: 1.
81. de Graaff AA, Delvoux B, Van de Vijver KK, Kyama CM, D'Hooghe TM, Dunselman GA, Romano A. Paired-box gene 2 is down-regulated in endometriosis and correlates with low epidermal growth factor receptor expression. Hum Reprod 2012; 27: 1676-84.
82. Jichan N, Xishi L, Guo SW. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in adenomyosis and its rectification by a histone deacetylase inhibitor and a demethylation agent. Reprod Sci 2010; 17: 995-1005.
83. Xue Q, Lin Z, Cheng YH, et al. Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biol Reprod 2007; 77: 681-7.
84. Xue Q, Zhou YF, Zhu SN, Bulun SE. Hypermethylation of the CpG island spanning from exon II to intron III is associated with steroidogenic factor 1 expression in stromal cells of endometriosis. Reprod Sci 2011; 18: 1080-4.
85. Izawa M, Taniguchi F, Uegaki T, et al. Demethylation of a nonpromoter cytosine-phosphate-guanine island in the aromatase gene may cause the aberrant up-regulation in endometriotic tissues. Fertil Steril 2010; 95: 33-9.
86. Wu Y, Strawn E, Basir Z, Halverson G, Guo SW. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Epigenetics 2006; 1: 106-11.
87. Ren F, Wang D, Jiang Y. Epigenetic inactivation of hMLH1 in the malignant transformation of ovarian endometriosis. Arch Gynecol Obstet 2012; 285: 215-21.
88. Martini M, Ciccarone M, Garganese G, et al. Possible involvement of hMLH1 p16(INK4a) and PTEN in the malignant transformation of endometriosis. Int J Cancer 2002; 102: 398-406.
89. Lelievre-Pegorier M, Merlet-Benichou C. The number of nephrons in the mammalian kidney: environmental influences play a determining role. Exp Nephrol 2000; 8: 63-5.
90. Xue Q, Lin Z, Yin P, et al. Transcriptional activation of steroidogenic factor-1 by hypomethylation of the 5' CpG island in endometriosis. J Clin Endocrinol Metab 2007; 92: 3261-7.
91. Noel JC, Borghese B, Vaiman D, Fayt I, Anaf V, Chapron C. Steroidogenic factor-1 expression in ovarian endometriosis. Appl Immunohistochem Mol Morphol 2010; 18: 258-61.
92. Bulun SE. Endometriosis. N Engl J Med 2009; 360: 268-79.
93. Wu Y, Starzinski-Powitz A, Guo SW. Prolonged stimulation with tumor necrosis factor-alpha induced partial methylation at PR-B promoter in immortalized epithelial-like endometriotic cells. Fertil Steril 2008; 90: 234-7.
94. Vestergaard AL, Thorup K, Knudsen UB, et al. Oncogenic events associated with endometrial and ovarian cancers are rare in endometriosis. Mol Hum Reprod 2011; 17: 758-61.
95. Borghese B, Barbaux S, Mondon F, et al. Research resource: genome- wide profiling of methylated promoters in endometriosis re veals a subtelomeric location of hypermethylation. Mol Endocrinol 2010; 24: 1872-85.
96. El-Maarri O, Kareta MS, Mikeska T, et al. A systematic search for DNA methyltransferase polymorphisms reveals a rare DNMT3L variant associated with subtelomeric hypomethylation. Hum Mol Genet 2009; 18: 1755-68.
97. Borghese B, Santulli P, Hequet D, et al. Genetic polymorphisms of DNMT3L involved in hypermethylation of chromosomal ends are associated with greater risk of developing ovarian endometriosis. Am J Pathol 2012; 180: 1781-6.
98. Wu Y, Strawn E, Basir Z, Halverson G, Guo SW. Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1, DNMT3A, and DNMT3B in women with endometriosis. Fertil Steril 2007; 87: 24-32.
99. Ahmadi A, Ng SC. Fertilizing ability of DNA-damaged spermatozoa. J Exp Zool 1999; 284: 696-704.
100. de Mouzon J, Goossens V, Bhattacharya S, et al. Assisted reproductive technology in Europe, 2006: results generated from European registers by ESHRE. Hum Reprod 2010; 25: 1851-62.
101. Halliday JL, Ukoumunne OC, Baker HW, et al. Increased risk of blastogenesis birth defects, arising in the first 4 weeks of pregnancy, after assisted reproductive technologies. Hum Reprod 2010; 25: 59-65.
102. Katari S, Turan N, Bibikova M, et al. DNA methylation and gene expression differences in children conceived in vitro or in vivo. Hum Mol Genet 2009; 18: 3769-78.
103. de Mouzon J, Goossens V, Bhattacharya S, et al. Assisted reproductive technology in Europe, 2007: results generated from European registers by ESHRE. Hum Reprod 2012; 27: 954-66.
104. Cardozo E, Pavone ME, Hirshfeld-Cytron JE. Metabolic syndrome and oocyte quality. Trends Endocrinol Metab 2011; 22: 103-9.
105. Market-Velker BA, Zhang L, Magri LS, Bonvissuto AC, Mann MR. Dual effects of superovulation: loss of maternal and paternal imprinted methylation in a dose-dependent manner. Hum Mol Genet 2010; 19: 36-51.
106. Doherty AS, Mann MR, Tremblay KD, Bartolomei MS, Schultz RM. Differential effects of culture on imprinted H19 expression in the preimplantation mouse embryo. Biol Reprod 2000; 62: 1526-35.
107. Fauque P, Ripoche MA, Tost J, et al. Modulation of imprinted gene network in placenta results in normal development of in vitro manipulated mouse embryos. Hum Mol Genet 2010; 19: 1779-90.
108. Sato A, Otsu E, Negishi H, Utsunomiya T, Arima T. Aberrant DNA methylation of imprinted loci in superovulated oocytes. Hum Reprod 2007; 22: 26-35.
109. Helmerhorst FM, Perquin DA, Donker D, Keirse MJ. Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies. BMJ 2004; 328: 261.
110. Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol 2004; 103: 551-63.
111. Shevell T, Malone FD, Vidaver J, et al. Assisted reproductive technology and pregnancy outcome. Obstet Gynecol 2005; 106: 1039-45.
112. Chen XK, Wen SW, Bottomley J, Smith GN, Leader A, Walker MC. In vitro fertilization is associated with an increased risk for preeclampsia. Hypertens Pregnancy 2009; 28: 1-12.
113. Romundstad LB, Romundstad PR, Sunde A, et al. Effects of technology or maternal factors on perinatal outcome after assisted fertilisation: a population-based cohort study. Lancet 2008; 372: 737-43.
114. Thomopoulos C, Tsioufis C, Michalopoulou H, Makris T, Papademetriou V, Stefanadis C. Assisted reproductive technology and pregnancy-related hypertensive complications: a systematic review. J Hum Hypertens 2013; 27(3): 148-57.
115. DeBaun MR, Niemitz EL, Feinberg AP. Association of in vitro fertilization with Beckwith-Wiedemann syndrome and epigenetic alterations of LIT1 and H19. Am J Hum Genet 2003; 72: 156-60.
116. Maher ER, Afnan M, Barratt CL. Epigenetic risks related to assisted reproductive technologies: epigenetics, imprinting, ART and icebergs? Hum Reprod 2003; 18: 2508-11.
117. Gicquel C, Gaston V, Mandelbaum J, Siffroi JP, Flahault A, Le Bouc Y. In vitro fertilization may increase the risk of Beckwith- Wiedemann syndrome related to the abnormal imprinting of the KCN1OT gene. Am J Hum Genet 2003; 72: 1338-41.
118. Cox GF, Burger J, Lip V, et al. Intracytoplasmic sperm injection may increase the risk of imprinting defects. Am J Hum Genet 2002; 71: 162-4.
119. Orstavik KH, Eiklid K, van der Hagen CB, et al. Another case of imprinting defect in a girl with Angelman syndrome who was conceived by intracytoplasmic semen injection. Am J Hum Genet 2003; 72: 218-9.
120. Ludwig M, Katalinic A, Gross S, Sutcliffe A, Varon R, Horsthemke B. Increased prevalence of imprinting defects in patients with Angelman syndrome born to subfertile couples. J Med Genet 2005; 42: 289-91.
121. Sutcliffe AG, Peters CJ, Bowdin S, et al. Assisted reproductive therapies and imprinting disorders--a preliminary British survey. Hum Reprod 2006; 21: 1009-11.
122. Bliek J, Terhal P, van den Bogaard MJ, et al. Hypomethylation of the H19 gene causes not only Silver-Russell syndrome (SRS) but also isolated asymmetry or an SRS-like phenotype. Am J Hum Genet 2006; 78: 604-14.
123. Kagami M, Nagai T, Fukami M, Yamazawa K, Ogata T. Silver- Russell syndrome in a girl born after in vitro fertilization: partial hypermethylation at the differentially methylated region of PEG1/MEST. J Assist Reprod Genet 2007; 24: 131-6.
124. Moll AC, Imhof SM, Cruysberg JR, et al. Incidence of retinoblastoma in children born after in-vitro fertilisation. Lancet 2003; 361: 309-10.
125. Puumala SE, Nelson HH, Ross JA, Nguyen RH, Damario MA, Spector LG. Similar DNA methylation levels in specific imprinting control regions in children conceived with and without assisted reproductive technology: a cross-sectional study. BMC Pediatr 2012; 12: 33.
126. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308: 1592-4.
127. Goswami D, Tannetta DS, Magee LA, et al. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset preeclampsia, but not normotensive intrauterine growth restriction. Placenta 2006; 27: 56-61.
128. Lok CA, Van Der Post JA, Sargent IL, et al. Changes in microparticle numbers and cellular origin during pregnancy and preeclampsia. Hypertens Pregnancy 2008; 27: 344-60.
129. Nishizawa H, Pryor-Koishi K, Kato T, Kowa H, Kurahashi H, Udagawa Y. Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia. Placenta 2007; 28: 487-97.
130. Toft JH, Lian IA, Tarca AL, et al. Whole-genome microarray and targeted analysis of angiogenesis-regulating gene expression (ENG, FLT1, VEGF, PlGF) in placentas from pre-eclamptic and smallfor- gestational-age pregnancies. J Matern Fetal Neonatal Med 2008; 21: 267-73.
131. Varkonyi T, Nagy B, Fule T, et al. Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar. Placenta 2011; 32 Suppl: S21-9.
132. Centlow M, Wingren C, Borrebaeck C, Brownstein MJ, Hansson SR. Differential gene expression analysis of placentas with increased vascular resistance and pre-eclampsia using whole-genome microarrays. J Pregnancy 2011; 2011: 472354.
133. Tsai S, Hardison NE, James AH, et al. Transcriptional profiling of human placentas from pregnancies complicated by preeclampsia reveals disregulation of sialic acid acetylesterase and immune signalling pathways. Placenta 2011; 32: 175-82.
134. Loset M, Mundal SB, Johnson MP, et al. A transcriptional profile of the decidua in preeclampsia. Am J Obstet Gynecol 2011; 204: 84 e1-27.
135. Chelbi ST, Vaiman D. Genetic and epigenetic factors contribute to the onset of preeclampsia. Mol Cell Endocrinol 2008; 282: 120-129.
136. Jia RZ, Zhang X, Hu P, et al. Screening for differential methylation status in human placenta in preeclampsia using a CpG island plus promoter microarray. Int J Mol Med 2012; 30: 133-41.
137. Yuen RK, Penaherrera MS, von Dadelszen P, McFadden DE, Robinson WP. DNA methylation profiling of human placentas reveals promoter hypomethylation of multiple genes in early-onset preeclampsia. Eur J Hum Genet 2010; 18: 1006-12.
138. Tsui DW, Chan KC, Chim SS, et al. Quantitative aberrations of hypermethylated RASSF1A gene sequences in maternal plasma in pre-eclampsia. Prenat Diagn 2007; 27: 1212-8.
139. Bellido ML, Radpour R, Lapaire O, et al. MALDI-TOF mass array analysis of RASSF1A and SERPINB5 methylation patterns in human placenta and plasma. Biol Reprod 2010; 82: 745-50.
140. Chelbi ST, Mondon F, Jammes H, et al. Expressional and epigenetic alterations of placental serine protease inhibitors: SERPINA3 is a potential marker of preeclampsia. Hypertension 2007; 49: 76-83.
141. Wang Z, Lu S, Liu C, Zhao B, Pei K, Tian L, Ma X. Expressional and epigenetic alterations of placental matrix metalloproteinase 9 in preeclampsia. Gynecol Endocrinol 2010; 26: 96-102.
142. Gascoin-Lachambre G, Buffat C, Rebourcet R, et al. Cullins in human intra-uterine growth restriction: expressional and epigenetic alterations. Placenta 2010; 31: 151-7.
143. Chelbi ST, Wilson ML, Veillard AC, et al. Genetic and epigenetic mechanisms collaborate to control SERPINA3 expression and its association with placental diseases. Hum Mol Genet 2012; 21: 1968-78.
144. Chelbi ST, Doridot L, Mondon F, et al. Combination of promoter hypomethylation and PDX1 overexpression leads to TBX15 decrease in vascular IUGR placentas. Epigenetics 2011; 6: 247-55.
145. Kulkarni A, Chavan-Gautam P, Mehendale S, Yadav H, Joshi S. Global DNA methylation patterns in placenta and its association with maternal hypertension in pre-eclampsia. DNA Cell Biol 2011; 30: 79-84.
146. McMillen IC, Robinson JS. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 2005; 85: 571-633.
147. Pham TD, MacLennan NK, Chiu CT, Laksana GS, Hsu JL, Lane RH. Uteroplacental insufficiency increases apoptosis and alters p53 gene methylation in the full-term IUGR rat kidney. Am J Physiol Regul Integr Comp Physiol 2003; 285: R962-70.
148. MacLennan NK, James SJ, Melnyk S, et al. Uteroplacental insufficiency alters DNA methylation, one-carbon metabolism, and histone acetylation in IUGR rats. Physiol Genomics 2004; 18: 43-50.
149. Vaiman D, Gascoin-Lachambre G, Boubred F, et al. The Intensity of IUGR-Induced Transcriptome Deregulations Is Inversely Correlated with the Onset of Organ Function in a Rat Model. PLoS One 2011; 6: e21222.
150. Fu Q, McKnight RA, Yu X, Callaway CW, Lane RH. Growth retardation alters the epigenetic characteristics of hepatic dual specificity phosphatase 5. FASEB J 2006; 20: 2127-9.
151. Eustache F, Mondon F, Canivenc-Lavier MC, et al. Chronic dietary exposure to a low-dose mixture of genistein and vinclozolin modifies the reproductive axis, testis transcriptome, and fertility. Environ Health Perspect 2009; 117: 1272-9.
152. Ke X, Lei Q, James SJ, et al. Uteroplacental insufficiency affects epigenetic determinants of chromatin structure in brains of neonatal and juvenile IUGR rats. Physiol Genomics 2006; 25: 16-28.
153. Coupe B, Amarger V, Grit I, Benani A, Parnet P. Nutritional programming affects hypothalamic organization and early response to leptin. Endocrinology 2010; 151: 702-13.
154. Konycheva G, Dziadek MA, Ferguson LR, et al. Dietary methyl donor deficiency during pregnancy in rats shapes learning and anxiety in offspring. Nutr Res 2011; 31: 790-804.
155. Ke X, McKnight RA, Caprau D, et al. Intrauterine growth restriction affects hippocampal dual specificity phosphatase 5 gene expression and epigenetic characteristics. Physiol Genomics 2011; 43: 1160-9.
156. Park JH, Stoffers DA, Nicholls RD, Simmons RA. Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J Clin Invest 2008; 118: 2316-24.
157. Pinney SE, Jaeckle Santos LJ, Han Y, Stoffers DA, Simmons RA. Exendin-4 increases histone acetylase activity and reverses epigenetic modifications that silence Pdx1 in the intrauterine growth retarded rat. Diabetologia 2011; 54: 2606-14.
158. Thompson RF, Fazzari MJ, Niu H, Barzilai N, Simmons RA, Greally JM. Experimental intrauterine growth restriction induces alterations in DNA methylation and gene expression in pancreatic islets of rats. J Biol Chem 2010; 285: 15111-8.
159. Monk D, Smith R, Arnaud P, et al. Imprinted methylation profiles for proximal mouse chromosomes 11 and 7 as revealed by methylation- sensitive representational difference analysis. Mamm Genome 2003; 14: 805-16.
160. Eggerding FA, Schonberg SA, Chehab FF, Norton ME, Cox VA, Epstein CJ. Uniparental isodisomy for paternal 7p and maternal 7q in a child with growth retardation. Am J Hum Genet 1994; 55: 253-65.
161. Lee DH, Singh P, Tsark WM, Szabo PE. Complete biallelic insulation at the H19/Igf2 imprinting control region position results in fetal growth retardation and perinatal lethality. PLoS One 2010; 5: e12630.
162. Goyal R, Leitzke A, Goyal D, Gheorghe CP, Longo LD. Antenatal maternal hypoxic stress: adaptations in fetal lung Renin- Angiotensin system. Reprod Sci 2011; 18: 180-9.
163. Zhou FC, Chen Y, Love A. Cellular DNA methylation program during neurulation and its alteration by alcohol exposure. Birth Defects Res A Clin Mol Teratol 2011; 91: 703-15.
164. Downing C, Johnson TE, Larson C, et al. Subtle decreases in DNA methylation and gene expression at the mouse Igf2 locus following prenatal alcohol exposure: effects of a methyl-supplemented diet. Alcohol 2011; 45: 65-71.
165. Liu Y, Balaraman Y, Wang G, Nephew KP, Zhou FC. Alcohol exposure alters DNA methylation profiles in mouse embryos at early neurulation. Epigenetics 2009; 4: 500-11.
166. Haycock PC, Ramsay M. Exposure of mouse embryos to ethanol during preimplantation development: effect on DNA methylation in the h19 imprinting control region. Biol Reprod 2009; 81: 618-27.
167. Woods AK, Hoffmann DS, Weydert CJ, et al. Adenoviral delivery of VEGF121 early in pregnancy prevents spontaneous development of preeclampsia in BPH/5 mice. Hypertension 2011; 57: 94-102.
168. Zhao L, Zhou H, Lu L, et al. Identification of quantitative trait loci controlling rice mature seed culturability using chromosomal segment substitution lines. Plant Cell Rep 2009; 28: 247-56.
169. Bobetsis YA, Barros SP, Lin DM, et al. Bacterial infection promotes DNA hypermethylation. J Dent Res 2007; 86: 169-74.
170. Gicquel C, Rossignol S, Cabrol S, et al. Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver- Russell syndrome. Nat Genet 2005; 37: 1003-7.
171. Eggermann T, Schonherr N, Meyer E, et al. Epigenetic mutations in 11p15 in Silver-Russell syndrome are restricted to the telomeric imprinting domain. J Med Genet 2006; 43: 615-6.
172. Schonherr N, Meyer E, Roos A, Schmidt A, Wollmann HA, Eggermann T. The centromeric 11p15 imprinting centre is also involved in Silver-Russell syndrome. J Med Genet 2007; 44: 59-63.
173. Netchine I, Rossignol S, Dufourg MN, et al. 11p15 imprinting center region 1 loss of methylation is a common and specific cause of typical Russell-Silver syndrome: clinical scoring system and epigenetic-phenotypic correlations. J Clin Endocrinol Metab 2007; 92: 3148-54.
174. Eggermann T, Meyer E, Caglayan AO, Dundar M, Schonherr N. ICR1 epimutations in llp15 are restricted to patients with Silver- Russell syndrome features. J Pediatr Endocrinol Metab 2008; 21: 59-62.
175. Binder G, Seidel AK, Martin DD, et al. The endocrine phenotype in silver-russell syndrome is defined by the underlying epigenetic alteration. J Clin Endocrinol Metab 2008; 93: 1402-7.
176. Eggermann T, Schonherr N, Jager S, et al. Segmental maternal UPD(7q) in Silver-Russell syndrome. Clin Genet 2008; 74: 486-9.
177. Wojdacz TK, Dobrovic A, Algar EM. Rapid detection of methylation change at H19 in human imprinting disorders using methylation- sensitive high-resolution melting. Hum Mutat 2008; 29: 1255-60.
178. Bartholdi D, Krajewska-Walasek M, Ounap K, et al. Epigenetic mutations of the imprinted IGF2-H19 domain in Silver-Russell syndrome (SRS): results from a large cohort of patients with SRS and SRS-like phenotypes. J Med Genet 2009; 46: 192-7.
179. Eggermann T. Silver-Russell and Beckwith-Wiedemann syndromes: opposite (epi)mutations in 11p15 result in opposite clinical pictures. Horm Res 2009; 71 Suppl 2: 30-5.
180. Eggermann T, Spengler S, Bachmann N, et al. Chromosome 11p15 duplication in Silver-Russell syndrome due to a maternally inherited translocation t(11;15). Am J Med Genet A 2010; 152A: 1484-7.
181. Demars J, Shmela ME, Rossignol S, et al. Analysis of the IGF2/H19 imprinting control region uncovers new genetic defects, including mutations of OCT-binding sequences, in patients with 11p15 fetal growth disorders. Hum Mol Genet 2010; 19: 803-14.
182. Turner CL, Mackay DM, Callaway JL, et al. Methylation analysis of 79 patients with growth restriction reveals novel patterns of methylation change at imprinted loci. Eur J Hum Genet 2010; 18: 648-55.
183. McMinn J, Wei M, Schupf N, Cusmai J, Johnson EB, Smith AC, Weksberg R, Thaker HM, Tycko B. Unbalanced placental expression of imprinted genes in human intrauterine growth restriction. Placenta 2006; 27: 540-9.
184. Koukoura O, Sifakis S, Zaravinos A, et al. Hypomethylation along with increased H19 expression in placentas from pregnancies complicated with fetal growth restriction. Placenta 2011; 32: 51-7.
185. Bourque DK, Avila L, Penaherrera M, von Dadelszen P, Robinson WP. Decreased placental methylation at the H19/IGF2 imprinting control region is associated with normotensive intrauterine growth restriction but not preeclampsia. Placenta 2010; 31: 197-202.
186. Tabano S, Colapietro P, Cetin I, et al. Epigenetic modulation of the IGF2/H19 imprinted domain in human embryonic and extraembryonic compartments and its possible role in fetal growth restriction. Epigenetics 2010; 5: 313-24.
187. Lambertini L, Lee TL, Chan WY, et al. Differential methylation of imprinted genes in growth-restricted placentas. Reprod Sci 2011; 18: 1111-7.
188. Banister CE, Koestler DC, Maccani MA, Padbury JF, Houseman EA, Marsit CJ. Infant growth restriction is associated with distinct patterns of DNA methylation in human placentas. Epigenetics 2011; 6: 920-7.
189. Michels KB, Harris HR, Barault L. Birthweight, maternal weight trajectories and global DNA methylation of LINE-1 repetitive elements. PLoS One 2011; 6: e25254.
190. Gesta S, Bluher M, Yamamoto Y, et al. Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc Natl Acad Sci USA 2006; 103: 6676-81.
191. Adkins RM, Tylavsky FA, Krushkal J. Newborn umbilical cord blood DNA methylation and gene expression levels exhibit limited association with birth weight. Chem Biodivers 2012; 9: 888-99.
192. Tobi EW, Heijmans BT, Kremer D, et al. DNA methylation of IGF2, GNASAS, INSIGF and LEP and being born small for gestational age. Epigenetics 2011; 6: 171-6.
193. Wang H, Ogawa M, Wood JR, et al. Genetic and epigenetic mechanisms combine to control MMP1 expression and its association with preterm premature rupture of membranes. Hum Mol Genet 2008; 17: 1087-96.